Clinical Trial Update: Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO) [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study (ZORO) evaluating whether goserelin can prevent chemotherapy-induced ovarian failure in breast cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED